Fusen Pharmaceutical Company Limited (HKG:1652)
Hong Kong · Delayed Price · Currency is HKD 1.020
+0.030 (3.03%)
Jun 22, 2026, 11:41 AM HKT
HKG:1652 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -11.78 | -188.78 | -36.28 | -34.61 | 16.65 |
Depreciation & Amortization | 39.5 | 41.69 | 35.8 | 34.16 | 23.79 |
Other Amortization | 0.02 | 0.02 | - | - | - |
Loss (Gain) From Sale of Assets | -6.81 | -0 | 1.12 | 1.67 | 12.04 |
Loss (Gain) From Sale of Investments | -0.59 | 0.34 | 0.31 | 37.99 | 21.02 |
Loss (Gain) on Equity Investments | -14.45 | 104.1 | 40.62 | 21.02 | 1.97 |
Stock-Based Compensation | - | 0.81 | 1.45 | 1.15 | - |
Provision & Write-off of Bad Debts | 25.94 | 9.08 | 17.04 | -4.71 | 0.91 |
Other Operating Activities | 22.5 | 15.98 | 6.81 | 15.4 | 1.99 |
Change in Accounts Receivable | -19.31 | 72.42 | 49.86 | -90.56 | 25.97 |
Change in Inventory | 39.02 | 24.64 | -51.07 | 11.2 | -16.43 |
Change in Accounts Payable | 24.85 | -44.08 | 3.93 | 61.5 | -6.47 |
Change in Unearned Revenue | -1.39 | 14.56 | -63.66 | 64.87 | -6 |
Change in Other Net Operating Assets | 27.66 | 82.96 | -26.12 | -8.6 | -27.66 |
Operating Cash Flow | 125.15 | 133.73 | -20.18 | 110.49 | 47.77 |
Operating Cash Flow Growth | -6.42% | - | - | 131.31% | -68.82% |
Capital Expenditures | -53.33 | -60.96 | -66.24 | -23.86 | -110.13 |
Sale of Property, Plant & Equipment | 21.7 | - | 0.17 | 0 | 1.63 |
Divestitures | 72.89 | - | - | - | - |
Sale (Purchase) of Intangibles | - | -15.34 | -22.27 | - | - |
Investment in Securities | - | 10.7 | -3.33 | 16.02 | -175.12 |
Other Investing Activities | -47.28 | -97.83 | -69.81 | -5.29 | 0.65 |
Investing Cash Flow | -6.02 | -163.42 | -161.48 | -13.13 | -282.98 |
Short-Term Debt Issued | - | - | - | 78.9 | 60 |
Long-Term Debt Issued | 300.28 | 776.09 | 340.98 | 206.25 | 230.33 |
Total Debt Issued | 300.28 | 776.09 | 340.98 | 285.14 | 290.33 |
Short-Term Debt Repaid | - | - | - | -83.9 | -52 |
Long-Term Debt Repaid | -374.04 | -735.66 | -223.9 | -223.76 | -193.91 |
Total Debt Repaid | -374.04 | -735.66 | -223.9 | -307.66 | -245.91 |
Net Debt Issued (Repaid) | -73.76 | 40.43 | 117.07 | -22.52 | 44.42 |
Repurchase of Common Stock | - | -6.46 | -15.99 | -10.07 | -7.39 |
Common Dividends Paid | - | - | - | -6.96 | -8.31 |
Other Financing Activities | 16.06 | -17.97 | -12.58 | -12.22 | -8.19 |
Financing Cash Flow | -57.7 | 15.99 | 88.5 | -51.77 | 20.53 |
Foreign Exchange Rate Adjustments | 1.36 | -0.09 | -0.11 | 1.45 | -1.29 |
Net Cash Flow | 62.79 | -13.79 | -93.26 | 47.04 | -215.98 |
Free Cash Flow | 71.82 | 72.77 | -86.42 | 86.63 | -62.37 |
Free Cash Flow Growth | -1.31% | - | - | - | - |
Free Cash Flow Margin | 26.27% | 22.32% | -15.28% | 17.62% | -16.17% |
Free Cash Flow Per Share | 0.10 | 0.10 | -0.12 | 0.12 | -0.08 |
Cash Interest Paid | 20.36 | 17.97 | 12.58 | 12.22 | 8.19 |
Cash Income Tax Paid | 0.39 | 0.85 | 11.09 | -3.33 | 9.4 |
Levered Free Cash Flow | 108.77 | 47.77 | -158.98 | 146.28 | -182.17 |
Unlevered Free Cash Flow | 121.49 | 60.36 | -151.11 | 154.02 | -177.02 |
Change in Working Capital | 70.83 | 150.5 | -87.05 | 38.41 | -30.59 |